piur imaging secures 4.9 million euros in Series A financing

Austrian medical technology company piur imaging has raised €4.9 million in a Series A funding round. With its AI-driven 3D tomographic ultrasound solutions, the startup plans to provide healthcare at affordable prices.

Vienna - piur imaging has successfully closed a €4.9 million Series A funding round. The round was led by Ascend Capital Partners, an EU healthtech VC. Aescuvest, a healthcare investment firm based in Munich, also participated as a new shareholder.

Ultrasound is one of the most important diagnostic imaging tools for vascular,thyroid, abdominal and cardiac diseases. It is cost-efficient, has no side effects and is well suited for imaging soft tissues and blood vessels.

Frederik Bender, Managing Director piur imaging

The startup offers PIUR tUS Infinity, a vendor-independent 3D tomographic ultrasound solution on the market. The technology enables the extension of a conventional ultrasound system by a tomography function, which allows volume images of organs and structures. Image acquisition and analysis are performed separately, enabling AI-based image analysis and asynchronous remote diagnosis. This makes ultrasound examinations less operator-dependent and more efficient.

The fresh funding will be invested by piur in research and development, marketing and sales, and partnerships. The company plans a major software update and the introduction of a second-generation sensor to improve the product's usability and performance. PIUR is also looking to expand its team and grow its user base. Piur plans to expand into the U.S. and expects to receive regulatory approval by the end of the year. The company is also planning extensive collaboration with a leading pharmaceutical company and a leading ultrasound company in the coming months.

The product is meeting market demand. The company has also already established a significant customer base in the DACH region

Sebastian Gührs, Partner & Head of Investment Aescuvest.

Frederik Bender, Managing Director of piur imaging, emphasizes the importance of ultrasound as a key diagnostic imaging tool. However, the accuracy of the diagnosis depends on the skills and experience of the physician. This is where piur comes in with its solution that enables accurate volume measurements, as opposed to previous estimates.

Aescuvest, based in Munich, Germany, is an investment company focused on financing digital healthcare companies. Through its investment platform, the company offers exclusive access to promising healthcare companies and enables direct investments via SPV structures. Investors thus have the opportunity to take advantage of lucrative investment opportunities in the healthcare sector.